Home LiteratureArticle Details
PMID: 9423286 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours.

Transgenic research ·Vol. 6 ·No. 6 ·1997-11-00 ·Pages 359-67

Baribault H, Wilson-Heiner M, Muller W, Penner J, Bakhiet N

Abstract

Keratin 8 and 18 are commonly used as tumorigenic markers for various types of carcinomas. They are known to be involved in cell migration, cell invasiveness, plasminogen activity and drug and radiation resistance. To ascertain a potential function for simple epithelium keratins in mammary adenocarcinoma in vivo, keratin-8-deficient mice (mK8) were mated with transgenic mice carrying the middle T oncogene driven by the MMTV promoter. The resulting mK8 knockout and control progeny carrying the middle T transgene developed mammary gland tumours with the same incidence. However, the onset of palpable mammary gland tumours occurred earlier in mK8 mutant than in control mice. This effect was prominent in males where the onset in control animals is delayed overall, because of the lower hormonal inducibility of the MMTV promoter. Metastatic foci were observed in the lungs of all females and of a few males, independently of the genotype. Histological analysis revealed no morphological differences of the tumorigenic cells in primary tumours nor in metastatic foci. As expected, keratin 8 was absent in the mK8 tumours. Keratin 7 (mK7), keratin 18 (mK18) and keratin 19 (mK19) protein were observed in both primary and metastatic foci. These results constitute the first in vivo analysis of the role of simple epithelium keratins in mammary carcinogenesis. It demonstrates that the latency, but not the incidence nor the morphological features, of PyV middle T-induced mammary gland tumours is affected by keratin 8 deficiency.

MeSH Terms
Age Factors Animals Antigens, Polyomavirus Transforming/biosynthesis,genetics Biomarkers, Tumor/analysis Female Heterozygote Keratins/analysis,biosynthesis,deficiency Lung/pathology Lung Neoplasms/genetics,pathology,secondary Male Mammary Glands, Animal/pathology Mammary Neoplasms, Animal/genetics,pathology Mammary Tumor Virus, Mouse/genetics Mice Mice, Knockout Mice, Transgenic Mitotic Index Sex Characteristics
Chemicals
Antigens, Polyomavirus Transforming Biomarkers, Tumor Keratins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Baribault H
Burnham Institute (founded as La Jolla Cancer Research Foundation), CA 92037, USA.
Wilson-Heiner M
Muller W
Penner J
Bakhiet N
References (31)
31 references, click to expand
  1. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor.
    J Cell Biol. 1996 Apr;133(2):345-57 PMID: 8609167
  2. Use of keratin antibodies in tumor diagnosis.
    Semin Cancer Biol. 1990 Jun;1(3):165-79 PMID: 1715788
  3. Tissue distribution of keratin 7 as monitored by a monoclonal antibody.
    Exp Cell Res. 1987 May;170(1):235-49 PMID: 2436934
  4. Evidence that the deep keratin filament systems of the Xenopus embryo act to ensure normal gastrulation.
    Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8736-40 PMID: 1382297
  5. Oncogenic regulation and function of keratins 8 and 18.
    Cancer Metastasis Rev. 1996 Dec;15(4):445-71 PMID: 9034603
  6. Transgenic models of tumor development.
    Science. 1991 Nov 22;254(5035):1161-7 PMID: 1957168
  7. PKC epsilon-related kinase associates with and phosphorylates cytokeratin 8 and 18.
    J Cell Biol. 1992 May;117(3):583-93 PMID: 1374067
  8. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice.
    Genes Dev. 1994 Dec 15;8(24):2964-73 PMID: 7528156
  9. Differential distribution of cytokeratins after microinjection of anti-cytokeratin monoclonal antibodies.
    Eur J Cell Biol. 1987 Jun;43(3):459-68 PMID: 2441990
  10. Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.
    Biochem J. 1996 Aug 1;317 ( Pt 3):763-9 PMID: 8760360
  11. Multiple drug resistance and intermediate filaments.
    Cancer Metastasis Rev. 1996 Dec;15(4):499-506 PMID: 9034606
  12. The differential expression of cytokeratin 18 in cisplatin-sensitive and -resistant human ovarian adenocarcinoma cells and its association with drug sensitivity.
    Cancer Res. 1995 Nov 15;55(22):5203-6 PMID: 7585575
  13. Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential.
    J Natl Cancer Inst. 1992 Feb 5;84(3):165-74 PMID: 1371813
  14. Mouse vimentin: structural relationship to fos, jun, CREB and tpr.
    Oncogene. 1990 May;5(5):645-55 PMID: 2140597
  15. TPS--a cytokeratin marker for therapy control in breast cancer.
    Scand J Clin Lab Invest Suppl. 1995;221:113-5 PMID: 7544480
  16. A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines.
    J Cell Sci. 1995 Mar;108 ( Pt 3):1071-82 PMID: 7542667
  17. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion.
    Proc Natl Acad Sci U S A. 1993 May 1;90(9):4261-5 PMID: 7683431
  18. Molecular and cellular biology of intermediate filaments.
    Annu Rev Biochem. 1988;57:593-625 PMID: 3052284
  19. Monoclonal antibodies against trophectoderm-specific markers during mouse blastocyst formation.
    Proc Natl Acad Sci U S A. 1980 Jul;77(7):4113-7 PMID: 6933460
  20. Cytokeratins in the histological diagnosis of malignant tumors.
    Int J Biol Markers. 1994 Apr-Jun;9(2):63-9 PMID: 7523543
  21. Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton.
    J Cell Biol. 1996 Nov;135(4):991-1007 PMID: 8922382
  22. Expression of cytokeratin confers multiple drug resistance.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5311-4 PMID: 7515497
  23. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator.
    J Biol Chem. 1996 Oct 11;271(41):25684-91 PMID: 8810346
  24. Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility.
    Am J Pathol. 1996 Jan;148(1):63-9 PMID: 8546227
  25. Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents.
    Clin Cancer Res. 1996 Jan;2(1):97-105 PMID: 9816096
  26. Intermediate filaments: structure, dynamics, function, and disease.
    Annu Rev Biochem. 1994;63:345-82 PMID: 7979242
  27. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.
    Cell. 1982 Nov;31(1):11-24 PMID: 6186379
  28. Mid-gestational lethality in mice lacking keratin 8.
    Genes Dev. 1993 Jul;7(7A):1191-202 PMID: 7686525
  29. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
    Mol Cell Biol. 1992 Mar;12(3):954-61 PMID: 1312220
  30. Function of maternal cytokeratin in Xenopus development.
    Nature. 1992 Jun 4;357(6377):413-5 PMID: 1375708
  31. Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18.
    Tumour Biol. 1994;15(4):210-22 PMID: 7524130
Article Info
Journal
Transgenic research
Abbr.
Transgenic Res
ISSN
0962-8819
Published
1997-11-00
Pages
359-67
Language
English
Region
Netherlands
NLM ID
9209120
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]